The role of the Asia-Pacific region in global drug development strategy

Drug Information Journal

Volumn 43, Issue 1, 2009, Pages 35-40

  Tsuei, S Edmund ^a  

^a Roche Products Pty Limited   (Australia)

Author keywords

Asia Pacific; Capability; Capacity; Commercial potential; Drug development potential

Indexed keywords

NEW DRUG;

ARTICLE; ASIA; CLINICAL TRIAL; COMMERCIAL PHENOMENA; COMPETITION; DISEASE COURSE; DRUG APPROVAL; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; ECONOMIC DEVELOPMENT; EUROPE; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; GOOD CLINICAL PRACTICE; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH PRACTITIONER; HUMAN; INSTITUTIONAL ETHICS; INTERNET; LIFESTYLE; MEDICAL EDUCATION; NORTH AMERICA; PACIFIC ISLANDS; PATIENT PARTICIPATION; POPULATION SIZE; PRIORITY JOURNAL; RESEARCH SUBJECT;

EID: 59849102086     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150904300107     Document Type: Article

References (7)

1. US Food and Drug Administration Website. Available at: http://wwwfda.gov. Accessed September 26, 2008.
2. DiMasi JA. The value of improving the productivity of the drug development process - faster times and better decisions. PharmacoEcon. 2002;20 (Suppl 3):1-10.
3. IMS Health Media Advisory. IMS Health reports global prescription sales grew 6.4 percent in 2007, to 712 billion. April 15, 2008. Available at: http://www.imshealth.com
4. Central Intelligence Agency. The World Fact Book. Available at: https://www.cia.gov/library/publications/the-world-factbook/index.html. April 15, 2008, update.
5. IMS Health Press Room. In the news: IMS predicts dramatic growth, points out potential perils in emerging markets. March 3, 2008. Available at: http://www.imshealth.com
6. US National Institute of Health. Clinical trials registry. Available at: http://www.clinicaltrials.gov/. Accessed February 7, 2008.
7. Hamadian L, Johansen AJ. Reviewing the ethical reviewers. GCPj. May 2008:8-10.